Persistence with mirabegron or antimuscarinic treatment for overactive bladder syndrome: Findings from the PERSPECTIVE registry study

ConclusionsTreatment persistence was longer for mirabegron compared with antimuscarinic initiators after controlling for patient characteristics. End of treatment persistence by any cause was also longer with mirabegron.

https://onlinelibrary.wiley.com/doi/10.1111/luts.12382?af=R

Source: LUTS: Lower Urinary Tract Symptoms - May 19, 2021 Category: Urology & Nephrology Authors: Kevin V. Carlson, Eric S. Rovner, Kavita V. Nair, Anna S. Deal, Rita M. Kristy, John C. Hairston Tags: ORIGINAL ARTICLE Source Type: research

More News: Health Management | Overactive Bladder | Overactive Bladder Syndrome | Study | Urology & Nephrology